The acid sphingomyelinase deficiency (ASMD) market comprises medications that are used for treating ASMD disorder. ASMD is a rare lysosomal storage disease caused due to mutation in sphingomyelin phosphodiesterase 1 (SMPD1) gene resulting in deficient activity of acid sphingomyelinase enzyme. This leads to accumulation of sphingomyelin in cells and tissues including brain, liver, and spleen. Currently, there is no approved drug for ASMD treatment and management relies on supportive measures. Various drugs are under research and development which can specifically target the underlying cause and provide curative treatment.
The acid sphingomyelinase deficiency (ASMD) market is estimated to be valued at USD 134.6 Mn in 2024 and is expected to reach USD 300 Mn by 2031, growing at a compound annual growth rate (CAGR) of 12.1% from 2024 to 2031.
Key Takeaways
Key players operating in the acid sphingomyelinase deficiency (ASMD) market are Novartis, Orchard Therapeutics, and REGENXBIO.
The key opportunities in the Acid Sphingomyelinase Deficiency (ASMD) Market include increasing research collaborations between biotech companies and academic institutions, rising investment in orphan drug development, and establishment of clinical trial networks to accelerate new treatment evaluation.
The major players are focused on expanding their clinical trial operations in the US and Europe. Companies are also evaluating opportunities in Asia Pacific region to conduct clinical trials and enable early patient access to investigational therapies.
Market Drivers
Growing research funding from government and private institutions to develop new treatment options for rare diseases like ASMD is a major market driver. For instance, in 2020, National Organization for Rare Disorders awarded USD 1.4 million in research grants focused on ASMD. Increasing awareness about ASMD through patient advocacy groups and social media also plays an important role in early diagnosis and treatment-seeking behavior, thereby fueling the market growth.
Market Restraints
High research and development costs associated with orphan drug development acts as a major restraint. Developing a treatment for rare disease requires huge financial investments. Limited patient pool and difficulties in patient recruitment pose significant challenges in completing clinical trials within stipulated timelines. This can impact the timely approval and commercialization of new treatment products.
Segment Analysis
The global acid sphingomyelinase deficiency (ASMD) market is segmented based on type, treatment, and end-user. By type, the market is classified into Type A and Type B. The Type A segment dominates the market as Type A is the most common and severe form of ASMD. It causes widespread lipid accumulation and multi organ involvement. By treatment, the market is bifurcated into enzyme replacement therapy (ERT) and others. The ERT segment dominates the market as it is the only approved treatment for ASMD currently. By end-user, the market is divided into hospitals, specialty clinics, research institutions. The hospitals segment holds the largest share as majority of ASMD patients are treated in hospitals.
Global Analysis
Regionally, North America dominates the global ASMD market and is expected to continue its dominance during the forecast period. This is attributed to the growing patient population, rising research activities, and availability of reimbursements. The Asia Pacific region is expected to grow at the fastest pace during the forecast period. This is owing to improving healthcare infrastructure, increasing healthcare spending, and rising awareness about the condition in Asia Pacific countries.
Get This Report in Japanese Language: 酸性スフィンゴミエリナーゼ欠損症（ASMD）市場
Get This Report in Korean Language: 산성 스핑고미엘린 분해효소 결핍증(ASMD) 시장
About Author:
Ravina Pandya, Content Writer, has a strong foothold in the market research industry. She specializes in writing well-researched articles from different industries, including food and beverages, information and technology, healthcare, chemical and materials, etc.
(https://www.linkedin.com/in/ravina-pandya-1a3984191)
Global Acid Sphingomyelinase Deficiency Drug Market Research Report - Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027 – DecisionDatabases.comThe comprehensive value chain analysis of the market will assist in attaining better product differentiation, along with detailed understanding of the core competency of each activity involved.
The market attractiveness analysis provided in the report aptly measures the potential value of the market providing business strategists with the latest growth opportunities.
The report classifies the market into different segments.
These segments are studied in detail incorporating the market estimates and forecasts at regional and country level.
The segment analysis is useful in understanding the growth areas and probable opportunities of the market.Download Free Sample Report of Global Acid Sphingomyelinase Deficiency Drug Market @ https://www.decisiondatabases.com/contact/download-sample-23211The report also covers the complete competitive landscape of the global Acid Sphingomyelinase Deficiency Drug market with company profiles of key players such as: Genzyme CorporationLa Jolla Pharmaceutical CompanyMerck & Co., Inc.Okklo Life Sciences BVOrphazyme ApSThe detailed description of each has been included, with information in terms of H.Q, future capacities, key mergers & acquisitions, financial overview, partnerships, collaborations, new product launches, new product developments and other latest industrial developments.SEGMENTATIONS IN THE REPORT: By TypeLJPC-0712ML-SA1OKL-1014Olipudase AlfaOR-0005OthersBy ApplicationHospitalClinicOthersBy Geography:North America (NA) – US, Canada, and MexicoEurope (EU) – UK, Germany, France, Italy, Russia, Spain & Rest of EuropeAsia-Pacific (APAC) – China, India, Japan, South Korea, Australia & Rest of APACLatin America (LA) – Brazil, Argentina, Peru, Chile & Rest of Latin AmericaMiddle East and Africa (MEA) – Saudi Arabia, UAE, Israel, South AfricaBrowse the complete Global Acid Sphingomyelinase Deficiency Drug Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027 @ https://www.decisiondatabases.com/ip/23211-acid-sphingomyelinase-deficiency-drug-market-report The Global Acid Sphingomyelinase Deficiency Drug Market has been exhibited in detail in the following chapters –Chapter 1 Acid Sphingomyelinase Deficiency Drug Market Preface Chapter 2 Executive SummaryChapter 3 Acid Sphingomyelinase Deficiency Drug Industry AnalysisChapter 4 Acid Sphingomyelinase Deficiency Drug Market Value Chain AnalysisChapter 5 Acid Sphingomyelinase Deficiency Drug Market Analysis By TypeChapter 6 Acid Sphingomyelinase Deficiency Drug Market Analysis By ApplicationChapter 7 Acid Sphingomyelinase Deficiency Drug Market Analysis By GeographyChapter 8 Competitive Landscape Of Acid Sphingomyelinase Deficiency Drug CompaniesChapter 9 Company Profiles Of Acid Sphingomyelinase Deficiency Drug IndustryPurchase the complete Global Acid Sphingomyelinase Deficiency Drug Market Research Report @ https://www.decisiondatabases.com/contact/buy-now-23211Other Reports by DecisionDatabases.com:Global Bronchitis Drug Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027Global Herpes Zoste Drug Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027Global Eosinophilic Esophagitis Drug Market Research Report – Industry Analysis, Size, Share, Growth, Trends and Forecast Till 2027About-Us:DecisionDatabases.com is a global business research reports provider, enriching decision makers and strategists with qualitative statistics.
DecisionDatabases.com is proficient in providing syndicated research report, customized research reports, company profiles and industry databases across multiple domains.Our expert research analysts have been trained to map client’s research requirements to the correct research resource leading to a distinctive edge over its competitors.
Acid lipase deficiency Market Research report provides a detailed analysis of of main manufactures and geographic regions,global market size, regional and country-level market size, segmentation market growth, market share, competitive Landscape, sales analysis, impact of domestic and global market players.
Acid lipase deficiency Market report includes definitions, classifications, applications, and industry chain structure, development trends, and key regions distributors analysis.The report also provides supply and demand Figures, revenue, revenue and shares.
value chain optimization, trade regulations, recent developments, opportunities analysis, strategic market growth analysis, product launches.Acid lipase deficiency market is expected to gain market growth in the forecast period of 2020 to 2027.
Data Bridge Market Research analyses the market is growing at a substantial CAGR in the above-mentioned research forecast period.Acid lipase deficiency market imparts a deep understanding of this industry vertical with key emphasis on the market dynamics and projected returns over the forecast period.Get Sample PDF of Acid lipase deficiency Market Report (including COVID19 Impact Analysis) @ https://www.databridgemarketresearch.com/request-a-sample/?dbmr=global-acid-lipase-deficiency-marketAcid lipase deficiencyAcid Lipase Deficiency Market Scope and Market Size:The acid lipase deficiency market is segmented of the basis of types, treatment, route of administration, end-user and distribution channel.
The growth among segments helps you analyze niche pockets of growth and strategies to approach the market and determine your core application areas and the difference in your target markets.Based on types, the acid lipase deficiency market is segmented into Wolman disease, Cholesteryl Ester Storage Disease (CESD) and others.The treatment segment for acid lipase deficiency market includes medication, hematopoietic stem cell transplantation, enzyme replacement therapy and others.On the basis of route of administration, acid lipase deficiency market is segmented into oral and parenteral.Key Players: Global Acid lipase deficiency MarketAlexion Pharmaceuticals, Inc, Synageva BioPharma Corp, ArmaGen, Bellicum Pharmaceuticals, Inc, Amicus Therapeutics, Inc. among other players domestic and global.
Acid Lipase Deficiency Market share data is available for Global, North America, Europe, Asia-Pacific, Middle East and Africa and South America separately.
Methylfolate Deficiency can lead to anemia.
Vitamin B helps the body to produce new cells.
Folic acid helps to create red blood cells, and these cells are very important in carrying oxygen throughout the body.
When your body does not have enough red blood cells, you develop anemia with primary symptoms, weakness and fatigue.
This is what makes getting enough folic acid each day very important.
